Overall vaccine effectiveness was 29% against COVID-19–associated hospitalization.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
In another COVID development, the FDA today announced full approval for the use of Paxlovid in adults at risk for more severe disease.
Data suggest an increased risk of new-onset mental illness only in SARS-CoV-2–positive patients aged 70 and older.
Experts from the Annenberg Public Policy Center prefer "Vaccination Safety Monitor" or "Vaccination Safety Watch" over VAERS.
Excess deaths were 22%, 22%, and 25% above baseline in low-, medium-, and high-vaccination states in the first year of the pandemic, but 23%, 22%, and 16%, respectively, in the second.
Particulate matter, nitrous oxide, and black carbon exposures were all associated with severe outcomes.
Maternal death occurred more often in patients who had cardiac arrest, acute kidney injury, or intracranial hemorrhage (brain bleed).
The 2 heart conditions occurred within a week of vaccination in under 40 cases per million doses delivered in kids 5 to 17 years old.
Pre-infection COVID-19 vaccination was tied to a lower likelihood of persistent symptoms 45 days after infection.
The incidence of new-onset type 1 diabetes was almost double in kids diagnosed as having COVID-19.
The prevalence of eating disorders more than doubled among adolescent girls after the pandemic began.
